COVID-19

3 in 4 adults around the world say they would get a COVID-19 vaccine

People wearing face masks walk at a shopping area, after Beijing Centre for Disease Prevention and Control announced that wearing face masks are no longer mandatory outdoor in Beijing, following the coronavirus disease (COVID-19) outbreak, China August 21, 2020. REUTERS/Tingshu Wang - RC25II9FQLSJ

Respondents from China were the most likely to say they'd get a vaccine once available. Image: REUTERS/Tingshu Wang

Joe Myers
Writer, Forum Agenda
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on COVID-19?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

  • New survey shows a majority of people would get a COVID-19 vaccine.
  • But people are not optimistic that one is likely to be ready by the end of 2020.
  • For those who wouldn’t get the vaccine, concern about side effects was the most commonly cited reason.

A new Ipsos survey, conducted on behalf of the World Economic Forum, shows that three-quarters of adults would get a vaccine for COVID-19 if it were available.

But nearly two-thirds (59%) don’t think one will be available by the end of 2020.

Have you read?

The study, which covers nearly 20,000 adults in 27 countries, also reveals where in the world take-up would be strongest.

Would you get a COVID-19 vaccine?

Of those surveyed, 74% strongly or somewhat agreed with the statement “if a vaccine for COVID-19 were available, I would get it”.

In China, this figure rose to 97%, but was lowest in Russia, Poland and Hungary.

Coronavirus china virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia  pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
Global Attitudes on a COVID-19 Vaccine interest in getting vaccine. Image: Ipsos

If not, why not?

The survey also asked those who said they wouldn’t get the vaccine why they wouldn’t consider it.

Globally, 56% said they were worried about the side effects, 29% had concerns about its effectiveness and 17% said they were against vaccines in general.

Coronavirus china virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia  pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
Ipsos Survey for WEF reasons for not getting a vaccine. Image: Ipsos

But will it be ready?

Nearly 3 in 5 adults don’t think a vaccine will be available to them by the end of 2020.

But, as with interest in getting a vaccine, China stands out. Nearly 90% of those surveyed strongly or somewhat agreed a vaccine is likely to be ready.

Coronavirus china virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia  pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
Ipsos Survey for WEF vaccine ready 2020. Image: Ipsos

Numerous pharmaceutical companies are working on vaccine trials and candidates, while organizations like the World Health Organization (WHO), Gavi and CEPI are also working to develop a vaccine and ensure any future solution is available for those most in need.

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, has warned about the risks of “vaccine nationalism: “Sharing finite supplies strategically and globally is actually in each country's national interest,” he said in August, as he urged WHO Member States to join the COVID-19 Vaccines Global Access (COVAX) Facility.

Loading...
Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Global Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Winding down COVAX – lessons learnt from delivering 2 billion COVID-19 vaccinations to lower-income countries

Charlotte Edmond

January 8, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum